Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2018

Enanta Pharma (ENTA) Misses Q1 EPS by 16c, Revenues Miss

February 6, 2019 4:05 PM EST

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of $1.25, $0.16 worse than the analyst estimate of $1.41. Revenue for the quarter came in at $69.9 million versus the consensus estimate of $71.27 million.

Enantas research and development programs are progressing well and we have many clinical... More